AJ
ABBV icon

Ashburton (Jersey)’s AbbVie ABBV Stock Holding History

Ashburton (Jersey)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-223
Closed -$24K – 63
2020
Q4 		$24K Hold
223
– – 0.01% 46
2020
Q3 		$22K Hold
223
– – 0.01% 44
2020
Q2 		$22K Sell
223
-815
-79% -$71.8K 0.01% 44
2020
Q1 		$79K Hold
1,038
– – 0.04% 41
2019
Q4 		$92K Sell
1,038
-62
-6% -$5.15K 0.04% 45
2019
Q3 		$83K Hold
1,100
– – 0.04% 46
2019
Q2 		$80K Buy
+1,100
New +$86.5K 0.04% 48
2017
Q1 		– Sell
-7,716
Closed -$483K – 50
2016
Q4 		$483K Hold
7,716
– – 0.21% 73
2016
Q3 		$487K Buy
+7,716
New +$500K 0.22% 77

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ashburton (Jersey)'s ABBV Position: Q1 2021 in Review

Ashburton (Jersey) sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 223 shares — an estimated $24K sold.

Ashburton (Jersey) first reported a position in ABBV in Q3 2016 and held it in 9 quarters. The position peaked at $487K in Q3 2016. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Ashburton (Jersey) reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Ashburton (Jersey) sold 223 AbbVie shares in Q1 2021, an estimated $24K.
  • Ashburton (Jersey) first reported a position in AbbVie in Q3 2016 and held it in 9 quarters.
  • Ashburton (Jersey)'s AbbVie position peaked at $487K in Q3 2016.
  • 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Ashburton (Jersey)'s 13F filing for Q1 2021, filed 26 May 2023.